KR101229625B1 - 전자기 치료 장치 및 방법 - Google Patents
전자기 치료 장치 및 방법 Download PDFInfo
- Publication number
- KR101229625B1 KR101229625B1 KR1020057016620A KR20057016620A KR101229625B1 KR 101229625 B1 KR101229625 B1 KR 101229625B1 KR 1020057016620 A KR1020057016620 A KR 1020057016620A KR 20057016620 A KR20057016620 A KR 20057016620A KR 101229625 B1 KR101229625 B1 KR 101229625B1
- Authority
- KR
- South Korea
- Prior art keywords
- delete delete
- electromagnetic field
- treatment device
- antenna
- body tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title abstract description 30
- 238000000940 electromagnetic therapy Methods 0.000 title description 8
- 230000005672 electromagnetic field Effects 0.000 claims abstract description 96
- 239000012190 activator Substances 0.000 claims abstract description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 20
- 201000010099 disease Diseases 0.000 claims abstract description 16
- 230000005855 radiation Effects 0.000 claims abstract description 14
- 230000001939 inductive effect Effects 0.000 claims abstract description 10
- 238000011282 treatment Methods 0.000 claims description 108
- 230000001225 therapeutic effect Effects 0.000 claims description 26
- 238000004804 winding Methods 0.000 claims description 14
- 239000000853 adhesive Substances 0.000 claims description 13
- 230000001070 adhesive effect Effects 0.000 claims description 13
- 239000004020 conductor Substances 0.000 claims description 12
- 230000000977 initiatory effect Effects 0.000 claims description 7
- 239000011505 plaster Substances 0.000 claims description 7
- 230000000694 effects Effects 0.000 claims description 6
- 230000000638 stimulation Effects 0.000 claims description 6
- 230000004044 response Effects 0.000 claims description 5
- 239000000565 sealant Substances 0.000 claims description 4
- 238000002560 therapeutic procedure Methods 0.000 claims description 4
- 230000005684 electric field Effects 0.000 claims description 3
- 230000006698 induction Effects 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 229910000859 α-Fe Inorganic materials 0.000 claims description 3
- 230000010267 cellular communication Effects 0.000 claims description 2
- 230000006806 disease prevention Effects 0.000 claims description 2
- 238000011321 prophylaxis Methods 0.000 claims 3
- 208000002193 Pain Diseases 0.000 abstract description 22
- 230000036407 pain Effects 0.000 abstract description 22
- 208000035475 disorder Diseases 0.000 abstract description 3
- 210000001519 tissue Anatomy 0.000 description 64
- 230000035876 healing Effects 0.000 description 12
- 230000004797 therapeutic response Effects 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 10
- 210000000988 bone and bone Anatomy 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 230000006978 adaptation Effects 0.000 description 5
- 210000004556 brain Anatomy 0.000 description 5
- 239000003990 capacitor Substances 0.000 description 5
- 230000005670 electromagnetic radiation Effects 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- 230000033001 locomotion Effects 0.000 description 5
- 208000020084 Bone disease Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 208000012659 Joint disease Diseases 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 210000004958 brain cell Anatomy 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 230000004907 flux Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010003246 arthritis Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 239000000428 dust Substances 0.000 description 3
- 208000002551 irritable bowel syndrome Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000001722 neurochemical effect Effects 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 210000004872 soft tissue Anatomy 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 241001061264 Astragalus Species 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 208000023178 Musculoskeletal disease Diseases 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 208000016247 Soft tissue disease Diseases 0.000 description 2
- 208000010040 Sprains and Strains Diseases 0.000 description 2
- 208000012931 Urologic disease Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 238000002266 amputation Methods 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 235000006533 astragalus Nutrition 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 210000003109 clavicle Anatomy 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 208000018631 connective tissue disease Diseases 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 230000009610 hypersensitivity Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000003601 intercostal effect Effects 0.000 description 2
- 208000028867 ischemia Diseases 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 210000004705 lumbosacral region Anatomy 0.000 description 2
- -1 moisture Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 201000008482 osteoarthritis Diseases 0.000 description 2
- 230000008058 pain sensation Effects 0.000 description 2
- 239000013618 particulate matter Substances 0.000 description 2
- 210000004417 patella Anatomy 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 210000004233 talus Anatomy 0.000 description 2
- 230000000451 tissue damage Effects 0.000 description 2
- 231100000827 tissue damage Toxicity 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 238000011269 treatment regimen Methods 0.000 description 2
- 210000001762 upper extremity of fibula Anatomy 0.000 description 2
- 208000014001 urinary system disease Diseases 0.000 description 2
- 208000000884 Airway Obstruction Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 208000018035 Dental disease Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 201000009273 Endometriosis Diseases 0.000 description 1
- 208000004145 Endometritis Diseases 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010023232 Joint swelling Diseases 0.000 description 1
- 208000003947 Knee Osteoarthritis Diseases 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 241000411545 Punargentus Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 1
- 208000014151 Stomatognathic disease Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 206010046996 Varicose vein Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 201000009267 bronchiectasis Diseases 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 208000003295 carpal tunnel syndrome Diseases 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 206010008129 cerebral palsy Diseases 0.000 description 1
- 208000036319 cervical spondylosis Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000004720 dielectrophoresis Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000008393 encapsulating agent Substances 0.000 description 1
- 206010014665 endocarditis Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 230000020169 heat generation Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 235000010299 hexamethylene tetramine Nutrition 0.000 description 1
- 239000004312 hexamethylene tetramine Substances 0.000 description 1
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 208000024765 knee pain Diseases 0.000 description 1
- 201000003723 learning disability Diseases 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 238000007443 liposuction Methods 0.000 description 1
- 229910001416 lithium ion Inorganic materials 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 231100000544 menstrual irregularity Toxicity 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- 229960004011 methenamine Drugs 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 201000003152 motion sickness Diseases 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 208000001297 phlebitis Diseases 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 238000004382 potting Methods 0.000 description 1
- 238000010248 power generation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000009188 pulsed electromagnetic field therapy Methods 0.000 description 1
- 238000004549 pulsed laser deposition Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 238000013125 spirometry Methods 0.000 description 1
- 208000005801 spondylosis Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000000946 synaptic effect Effects 0.000 description 1
- 201000004415 tendinitis Diseases 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 208000027185 varicose disease Diseases 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/004—Magnetotherapy specially adapted for a specific therapy
- A61N2/008—Magnetotherapy specially adapted for a specific therapy for pain treatment or analgesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Magnetic Treatment Devices (AREA)
- Electrotherapy Devices (AREA)
- Radiation-Therapy Devices (AREA)
Abstract
Description
Claims (93)
- 치료 장치에 있어서,전자기장 발생기;상기 전자기장 발생기에 연결되며 상기 전자기장을 방사하도록 구성되는 안테나;상기 전자기장 발생기에 연결된 전원;상기 전원을 둘러싸는 고리형 링;상기 고리형 링 둘레에 감긴 권선; 및상기 전자기장의 방사를 개시시키는 액티베이터를 포함하고,상기 치료 장치는 자급식(self-contained)이며 휴대용인 것인, 치료 장치.
- 제1항에 있어서, 상기 안테나는 인쇄 회로 기판 상에 안테나 도전체를 포함하는 것인 치료 장치.
- 제2항에 있어서, 상기 전원은 배터리인 것인 치료 장치.
- 제3항에 있어서, 상기 치료 장치는 신체 조직에 교류가 유도되도록 상기 신체 조직 상에 배치되어 적어도 하나의 세포간 전달(cellular communication) 또는 세포 자극을 촉진시키는 것인 치료 장치.
- 삭제
- 제3항에 있어서, 상기 고리형 링은 계단식 단면을 갖고, 상기 고리형 링의 상측 및 외측에 감긴 권선은 상기 안테나 도전체에 연결되는 것인 치료 장치.
- 제3항에 있어서, 상기 고리형 링은 페라이트 링을 포함하는 것인 치료 장치.
- 제3항에 있어서, 상기 고리형 링은 절연성 자기 링을 포함하는 것인 치료 장치.
- 제4항에 있어서, 상기 신체 조직에 유도된 교류는 상기 안테나 도전체의 방향과 평행하거나 수직인 것인 치료 장치.
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 치료 장치에 있어서,전자기장 발생기;상기 전자기장 발생기에 연결되며 상기 전자기장을 방사하도록 구성되는 안테나;상기 전자기장 발생기에 연결된 전원;상기 전원을 둘러싸는 고리형 링;상기 고리형 링 둘레에 감긴 권선; 및상기 전자기장 방사를 개시시키는 액티베이터를 포함하고,상기 치료 장치는 자급식이고 휴대용이며, 신체 조직에서 교류를 유도하도록 상기 신체 조직의 표면 상에 배치되는 것인, 치료 장치.
- 제45항에 있어서, 상기 전자기장 발생기는 정현파 발생기를 포함하는 것인 치료 장치.
- 제46항에 있어서, 상기 정현파 주파수는 27±0.5 ㎒인 것인 치료 장치.
- 제45항에 있어서, 상기 치료 장치를 밀봉하는 밀봉제를 더 포함하는 치료 장치.
- 제45항에 있어서, 상기 전원은 10V DC 미만인 것인 치료 장치.
- 제45항에 있어서, 상기 신체 조직의 온도는 상기 치료 장치의 동작에 의해 실질적으로 변하지 않는 것인 치료 장치.
- 제45항에 있어서, 상기 치료 장치를 위한 평균 유효 방사 전력은 45 ㎽ 미만인 것인 치료 장치.
- 제51항에 있어서, 상기 치료 장치를 위한 최대 유효 방사 전력 밀도는 상기 신체 조직의 표면에서 측정된 평방 센티미터 당 100 ㎼ 미만인 것인 치료 장치.
- 제45항에 있어서, 상기 액티베이터는 1회 사용 스위치인 것인 치료 장치.
- 제45항에 있어서, 상기 전자기장의 적어도 일부를 상기 신체 조직을 향해 편향시키기 위해 상기 안테나 위에 배치된 편향 차폐물을 더 포함하는 치료 장치.
- 제45항에 있어서, 상기 치료 장치는 일회용인 것인 치료 장치.
- 제45항에 있어서, 상기 전자기장은 펄스인 것인 치료 장치.
- 제56항에 있어서, 상기 펄스 전자기장의 듀티 사이클과 펄스 반복 레이트 중 적어도 하나를 변경하는 것을 더 포함하는 치료 장치.
- 제57항에 있어서, 상기 듀티 사이클은 8 %와 10 % 사이에 있는 것인 치료 장치.
- 제56항에 있어서, 상기 펄스 전자기장의 세기를 높이기 위해 유도성의 고전압 발생기를 더 포함하는 치료 장치.
- 제45항에 있어서, 상기 치료 장치가 동작하고 있음을 나타내는 인디케이터를 더 포함하는 치료 장치.
- 제60항에 있어서, 상기 인디케이터는 발광 다이오드, 음향 발생기, 및 전광 디스플레이 중 하나를 포함하는 것인 치료 장치.
- 제45항에 있어서, 상기 전원은 재충전 가능한 것인 치료 장치.
- 제62항에 있어서, 상기 전원의 재충전은 외부 소스로부터 안테나 또는 별도의 코일에서의 전류 유도에 의한 것인 치료 장치.
- 제45항에 있어서, 상기 신체 조직의 상태 또는 상기 치료 장치의 상태를 나타내는 상태 신호를 제공하는 회로부를 더 포함하는 치료 장치.
- 제64항에 있어서, 상기 상태 신호를 수신하고, 응답시, 상기 전자기장의 유전영동(dielectrophoretic) 또는 이온영동(ionphoretic) 효과에 의한 약학제 또는 화학제 전달을 변경하는 회로부를 더 포함하는 치료 장치.
- 제45항에 있어서, 상기 장치의 중량은 12 g 미만인 것인 치료 장치.
- 제45항에 있어서, 상기 장치의 면적은 20 ㎠ 미만인 것인 치료 장치.
- 제45항에 있어서, 상기 신체 조직에 유도된 교류는 상기 안테나 도전체의 방향과 평행하거나 수직인 것인 치료 장치.
- 제45항에 있어서, 상기 치료 장치의 두께는 10 mm 미만인 것인 치료 장치.
- 제45항에 있어서, 상기 안테나는 직경이 9 cm 미만이고, 길이가 27 cm 미만인 것인 치료 장치.
- 제45항에 있어서, 상기 안테나의 두께는 5 mm 미만인 것인 치료 장치.
- 제45항에 있어서, 상기 신체 조직에 유도된 전기장은 상기 안테나 도전체의 방향과 평행하거나 수직인 것인 치료 장치.
- 치료 전달 시스템에 있어서,패치, 붕대, 패드, 보조대(brace), 끈(strap), 테이프, 접착제 및 석고붕대로 이루어진 그룹 중의 요소; 및상기 그룹 중의 요소와 관련된 치료 장치를 포함하고, 상기 치료 장치는,전자기장 발생기;상기 전자기장 발생기에 연결되며 상기 전자기장을 방사하도록 구성되는 안테나;상기 전자기장 발생기에 연결된 전원;상기 전원을 둘러싸는 고리형 링;상기 고리형 링 둘레에 감긴 권선; 및상기 전자기장 방사를 개시시키는 액티베이터를 포함하고,상기 치료 장치는 자급식이고 휴대용이며, 신체 조직에서 교류를 유도하도록 상기 신체 조직의 표면 상에 배치되는 것인 치료 전달 시스템.
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 치료 장치에 있어서,전자기장 발생기;상기 전자기장 발생기에 연결되며 상기 전자기장을 방사하도록 구성되는 안테나;상기 안테나와 상기 전자기장 발생기에 연결된 튜닝 코일;상기 전자기장 발생기에 연결된 전원;상기 전원을 둘러싸는 고리형 링;상기 고리형 링 둘레에 감긴 권선; 및상기 전자기장 방사를 개시시키는 액티베이터를 포함하고,상기 치료 장치는 자급식이고 휴대용이며, 신체 조직에서 교류를 유도하도록 상기 신체 조직의 표면 상에 배치되는 것인 치료 장치.
- 제89항에 있어서, 상기 치료 장치를 밀봉하는 밀봉제를 더 포함하는 치료 장치.
- 제89항에 있어서, 상기 전원은 10V DC 미만인 것인 치료 장치.
- 치료 전달 시스템으로서,패치, 붕대, 패드, 보조대(brace), 끈(strap), 테이프, 접착제 및 석고붕대로 이루어진 그룹 중의 요소;상기 그룹 중의 요소와 관련된 치료 장치를 포함하고, 상기 치료 장치는,전자기장 발생기;상기 전자기장 발생기에 연결되며 상기 전자기장을 방사하도록 구성되는 안테나;상기 안테나와 상기 전자기장 발생기에 연결된 튜닝 코일;상기 전자기장 발생기에 연결된 전원;상기 전원을 둘러싸는 고리형 링;상기 고리형 링 둘레에 감긴 권선; 및상기 전자기장 방사를 개시시키는 액티베이터를 포함하고,상기 치료 장치는 자급식이고 휴대용이며, 신체 조직에서 교류를 유도하도록 상기 신체 조직의 표면 상에 배치되는 것인 치료 전달 시스템.
- 질병 예방 처치 시스템에 있어서,패치, 붕대, 패드, 보조대(brace), 끈(strap), 테이프, 접착제 및 석고붕대로 이루어진 그룹 중의 요소;상기 그룹 중의 요소와 관련된 질병 예방 처치 장치를 포함하고, 상기 질병 예방 처치 장치는,전자기장 발생기;상기 전자기장 발생기에 연결되며 상기 전자기장을 방사하도록 구성되는 안테나;상기 안테나와 상기 전자기장 발생기에 연결된 튜닝 코일;상기 전자기장 발생기에 연결된 전원;상기 전원을 둘러싸는 고리형 링;상기 고리형 링 둘레에 감긴 권선; 및상기 전자기장 방사를 개시시키는 액티베이터를 포함하고,상기 질병 예방 처치 장치는 자급식이고 휴대용이며, 신체 조직에 교류를 유도하도록 상기 신체 조직의 표면 상에 배치되는 것인 질병 예방 처치 시스템.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/384,101 | 2003-03-06 | ||
US10/384,101 US7551957B2 (en) | 2003-03-06 | 2003-03-06 | Electromagnetic therapy device and methods |
US10/442,448 | 2003-05-21 | ||
US10/442,448 US8412328B2 (en) | 2003-03-06 | 2003-05-21 | Electromagnetic therapy device and methods |
PCT/US2004/006319 WO2004080531A2 (en) | 2003-03-06 | 2004-03-03 | Electromagnetic therapy device and methods |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20060008291A KR20060008291A (ko) | 2006-01-26 |
KR101229625B1 true KR101229625B1 (ko) | 2013-02-04 |
Family
ID=32993813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020057016620A Expired - Fee Related KR101229625B1 (ko) | 2003-03-06 | 2004-03-03 | 전자기 치료 장치 및 방법 |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1606010B1 (ko) |
JP (1) | JP2006519680A (ko) |
KR (1) | KR101229625B1 (ko) |
AU (1) | AU2004220656A1 (ko) |
CA (1) | CA2518210C (ko) |
MX (1) | MXPA05009446A (ko) |
WO (1) | WO2004080531A2 (ko) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101483843B1 (ko) * | 2013-02-28 | 2015-01-16 | 원텍 주식회사 | 전자계 펄스를 이용한 이명/난청 치료기 |
KR101673182B1 (ko) * | 2015-07-30 | 2016-11-07 | 주식회사 리메드 | 자기장을 이용하는 의료 장치 |
KR102654857B1 (ko) | 2023-09-14 | 2024-04-05 | 주식회사 웰비즈인터내셔날 | 두피 자극 및 약액 도포 장치 |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7256019B2 (en) | 2001-08-29 | 2007-08-14 | Ge Healthcare Bio-Sciences Corp. | Terminal phosphate blocked nucleoside polyphosphates |
KR100951410B1 (ko) * | 2007-09-28 | 2010-04-07 | 한국과학기술원 | 전자기력을 이용한 세포 자극기 |
US10149982B2 (en) | 2009-03-11 | 2018-12-11 | University Of South Florida | Prevention and treatment of brain diseases and disorders related to abnormal protein aggregation through electromagnetic field treatment |
WO2010105035A2 (en) | 2009-03-11 | 2010-09-16 | University Of South Florida | Prevention, treatment, and diagnosis of alzheimer's disease through electromagnetic field exposure |
HUP0900218A2 (en) * | 2009-04-09 | 2010-11-29 | Lazar Ibolya Farkasne | Instrument for influencing function of cells |
KR101106834B1 (ko) * | 2011-04-08 | 2012-01-19 | 황주영 | 오심·구토 제어용 저주파 전기 자극 신호 발생장치 |
KR101273879B1 (ko) * | 2011-08-19 | 2013-06-17 | (주)센트로닉스 | 피부 자극용 전동모듈 |
ITTO20110794A1 (it) * | 2011-09-06 | 2013-03-07 | Tss Medical Lab S R L | Dispositivo autonomo, portatile per terapia elettromagnetica del dolore |
WO2013059804A1 (en) * | 2011-10-20 | 2013-04-25 | Bioelectronics Corp. | Pulsed electromagnetic field device with adhesive applicator |
US11911629B2 (en) | 2013-03-11 | 2024-02-27 | NeurEM Therapeutics, Inc. | Treatment of primary and metastatic brain cancers by transcranial electromagnetic treatment |
US11813472B2 (en) | 2013-03-11 | 2023-11-14 | NeuroEM Therapeutics, Inc. | Systems for sensing proper emitter array placement |
US10765879B2 (en) | 2013-03-11 | 2020-09-08 | NeuroEM Therapeutics, Inc. | Electromagnetic treatment of brain and body disorders |
US11759650B2 (en) | 2013-03-11 | 2023-09-19 | NeuroEM Therapeutics, Inc. | Immunoregulation, brain detoxification, and cognitive protection by electromagnetic treatment |
US11752356B2 (en) | 2013-03-11 | 2023-09-12 | NeuroEM Therapeutics, Inc. | Systems for controlling power to differently loaded antenna arrays |
US12318624B2 (en) | 2013-03-11 | 2025-06-03 | NeuroEM Therapeutics, Inc. | Brain immunoregulation through transcranial electromagnetic treatment |
NZ711655A (en) * | 2013-03-12 | 2019-03-29 | Valencia Tech Corporation | Implantable electroacupuncture device employing a high impedance coin-cell battery as a primary power source |
KR101412729B1 (ko) * | 2013-10-30 | 2014-06-30 | 연세대학교 원주산학협력단 | 전기 자극, 광 및 자기장을 이용한 치료 장치 및 그 제어 방법 |
US11794028B2 (en) | 2014-03-11 | 2023-10-24 | NeuroEM Therapeutics, Inc. | Transcranial electromagnetic treatment |
CN104434490B (zh) * | 2014-12-18 | 2017-01-18 | 巩法桃 | 中枢神经致下肢偏瘫康复仪 |
CN104523272A (zh) * | 2014-12-25 | 2015-04-22 | 高德杰 | 结核病检查治疗仪 |
KR101695096B1 (ko) * | 2015-06-18 | 2017-01-10 | (주)휴레브 | 복합 전자기 치료 장치 |
GB201609981D0 (en) * | 2016-06-08 | 2016-07-20 | Magstim The Company Ltd | Magnetic stimulation coil arrangement |
RO132423A2 (ro) * | 2016-08-26 | 2018-03-30 | Marian Velcea | Dispozitiv rezonant, aparat şi metodă pentru stimularea electromagnetică de înaltă frecvenţă a punctelor de acupunctură şi a altor zone electrodermice active () |
JP7342127B2 (ja) * | 2018-12-18 | 2023-09-11 | パイオミック メディカル アクチェンゲゼルシャフト | 治療装置 |
KR20220032729A (ko) * | 2020-09-08 | 2022-03-15 | (주)보우메디텍 | 자극을 제공하는 웨어러블 디바이스 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4850372A (en) * | 1987-08-25 | 1989-07-25 | The Johns Hopkins University | Electromagnetic non-invasive measurement and monitoring system for osteoporosis |
US4942884A (en) * | 1987-06-15 | 1990-07-24 | Matsushita Electric Works, Ltd. | Portable battery powered electromagnetic therapy application |
US6334069B1 (en) * | 1998-01-15 | 2001-12-25 | Regenesis Biomedical, Inc. | Pulsed electromagnetic energy treatment apparatus and method |
-
2004
- 2004-03-03 KR KR1020057016620A patent/KR101229625B1/ko not_active Expired - Fee Related
- 2004-03-03 WO PCT/US2004/006319 patent/WO2004080531A2/en active Application Filing
- 2004-03-03 EP EP04716844A patent/EP1606010B1/en not_active Expired - Lifetime
- 2004-03-03 CA CA2518210A patent/CA2518210C/en not_active Expired - Fee Related
- 2004-03-03 AU AU2004220656A patent/AU2004220656A1/en not_active Abandoned
- 2004-03-03 JP JP2006508990A patent/JP2006519680A/ja active Pending
- 2004-03-03 MX MXPA05009446A patent/MXPA05009446A/es active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4942884A (en) * | 1987-06-15 | 1990-07-24 | Matsushita Electric Works, Ltd. | Portable battery powered electromagnetic therapy application |
US4850372A (en) * | 1987-08-25 | 1989-07-25 | The Johns Hopkins University | Electromagnetic non-invasive measurement and monitoring system for osteoporosis |
US6334069B1 (en) * | 1998-01-15 | 2001-12-25 | Regenesis Biomedical, Inc. | Pulsed electromagnetic energy treatment apparatus and method |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101483843B1 (ko) * | 2013-02-28 | 2015-01-16 | 원텍 주식회사 | 전자계 펄스를 이용한 이명/난청 치료기 |
KR101673182B1 (ko) * | 2015-07-30 | 2016-11-07 | 주식회사 리메드 | 자기장을 이용하는 의료 장치 |
KR102654857B1 (ko) | 2023-09-14 | 2024-04-05 | 주식회사 웰비즈인터내셔날 | 두피 자극 및 약액 도포 장치 |
Also Published As
Publication number | Publication date |
---|---|
WO2004080531A3 (en) | 2004-11-04 |
KR20060008291A (ko) | 2006-01-26 |
EP1606010A2 (en) | 2005-12-21 |
AU2004220656A1 (en) | 2004-09-23 |
CA2518210A1 (en) | 2004-09-23 |
EP1606010B1 (en) | 2012-02-22 |
CA2518210C (en) | 2015-06-02 |
WO2004080531A2 (en) | 2004-09-23 |
EP1606010A4 (en) | 2010-01-13 |
MXPA05009446A (es) | 2006-04-07 |
JP2006519680A (ja) | 2006-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101229625B1 (ko) | 전자기 치료 장치 및 방법 | |
US8412328B2 (en) | Electromagnetic therapy device and methods | |
US20140249355A1 (en) | Pulsed electromagnetic field device with adhesive applicator | |
CA2945350A1 (en) | Electromagnetic therapy device and methods | |
US20180318595A1 (en) | Insole Electromagnetic Therapy Device | |
US4846178A (en) | Electric field therapeutic apparatus | |
US7740574B2 (en) | Electromagnetic treatment induction apparatus and method for using same | |
GB2486400A (en) | Portable therapeutic device | |
US20070150035A1 (en) | Multiple Selectable Field/Current-Voltage Pads Having Individually Powered and Controlled Cells | |
CN104039390B (zh) | 具有粘性敷贴器的脉冲电磁场装置 | |
TWM541866U (zh) | 軟薄膜微電極裝置 | |
EP0252594B1 (en) | Portable electro-therapy system | |
AU2014201303B2 (en) | Electromagnetic Therapy Device and Methods | |
CN211634889U (zh) | 中频电刺激可穿戴踝泵康复治疗仪 | |
JPH04135572A (ja) | 骨折治療用電気治療装置 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0105 | International application |
Patent event date: 20050906 Patent event code: PA01051R01D Comment text: International Patent Application |
|
PG1501 | Laying open of application | ||
A201 | Request for examination | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20090227 Comment text: Request for Examination of Application |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20110107 Patent event code: PE09021S01D |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20111128 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20121028 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20130129 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20130129 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
FPAY | Annual fee payment |
Payment date: 20160113 Year of fee payment: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20160113 Start annual number: 4 End annual number: 4 |
|
FPAY | Annual fee payment |
Payment date: 20170303 Year of fee payment: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20170303 Start annual number: 5 End annual number: 5 |
|
FPAY | Annual fee payment |
Payment date: 20190320 Year of fee payment: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20190320 Start annual number: 7 End annual number: 7 |
|
FPAY | Annual fee payment |
Payment date: 20200121 Year of fee payment: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20200121 Start annual number: 8 End annual number: 8 |
|
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20211109 |